249 related articles for article (PubMed ID: 34298645)
21. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies.
Elsayed M; Abdelrahim M
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917380
[TBL] [Abstract][Full Text] [Related]
22. Systemic anti-commensal response to fungi analyzed by flow cytometry is related to gut mycobiome ecology.
Moreno-Sabater A; Autaa G; Sterlin D; Jerbi A; Villette R; Holm JB; Parizot C; Selim S; Senghor Y; Ghillani-Dalbin P; Bachmeyer C; Hennequin C; Gorochov G; Larsen M
Microbiome; 2020 Nov; 8(1):159. PubMed ID: 33190643
[TBL] [Abstract][Full Text] [Related]
23. [A Review of Metabolic Stress and Development of Pancreatic Cancer].
Li JT; Lei MZ; Lei QY; Yin M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):5-10. PubMed ID: 33474881
[TBL] [Abstract][Full Text] [Related]
24. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.
Brind'Amour A; Webb M; Parapini M; Sidéris L; Segedi M; Chung SW; Chartier-Plante S; Dubé P; Scudamore CH; Kim PTW
Clin Exp Metastasis; 2021 Apr; 38(2):187-196. PubMed ID: 33486670
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.
Cheng RF; Wang J; Zhang JY; Sun L; Zhao YR; Qiu ZQ; Sun BC; Sun Y
Chin J Cancer; 2016 Jul; 35(1):64. PubMed ID: 27371108
[TBL] [Abstract][Full Text] [Related]
26. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
27. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
Hong BY; Sobue T; Choquette L; Dupuy AK; Thompson A; Burleson JA; Salner AL; Schauer PK; Joshi P; Fox E; Shin DG; Weinstock GM; Strausbaugh LD; Dongari-Bagtzoglou A; Peterson DE; Diaz PI
Microbiome; 2019 Apr; 7(1):66. PubMed ID: 31018870
[TBL] [Abstract][Full Text] [Related]
29. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
30. The Microbiome in PDAC-Vantage Point for Future Therapies?
Pfisterer N; Lingens C; Heuer C; Dang L; Neesse A; Ammer-Herrmenau C
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497456
[TBL] [Abstract][Full Text] [Related]
31. Mycobiota dysbiosis and gastric tumorigenesis.
Papon N; Hohl TM; Zhai B
Theranostics; 2021; 11(15):7488-7490. PubMed ID: 34158862
[TBL] [Abstract][Full Text] [Related]
32. Zeb1 in Stromal Myofibroblasts Promotes
Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC
Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature.
Wald P; Liu XS; Pettit C; Dillhoff M; Manilchuk A; Schmidt C; Wuthrick E; Chen W; Williams TM
Oncotarget; 2017 Sep; 8(42):73345-73361. PubMed ID: 29069873
[TBL] [Abstract][Full Text] [Related]
35. Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.
Hedegger K; Algül H; Lesina M; Blutke A; Schmid RM; Schneider MR; Dahlhoff M
Mol Oncol; 2020 Aug; 14(8):1653-1669. PubMed ID: 32335999
[TBL] [Abstract][Full Text] [Related]
36. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
37. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
38. Oral microbiome and pancreatic cancer.
Wei AL; Li M; Li GQ; Wang X; Hu WM; Li ZL; Yuan J; Liu HY; Zhou LL; Li K; Li A; Fu MR
World J Gastroenterol; 2020 Dec; 26(48):7679-7692. PubMed ID: 33505144
[TBL] [Abstract][Full Text] [Related]
39. The microbiota and microbiome in pancreatic cancer: more influential than expected.
Wei MY; Shi S; Liang C; Meng QC; Hua J; Zhang YY; Liu J; Zhang B; Xu J; Yu XJ
Mol Cancer; 2019 May; 18(1):97. PubMed ID: 31109338
[TBL] [Abstract][Full Text] [Related]
40. Ductal
Xu Y; Liu J; Nipper M; Wang P
Ann Pancreat Cancer; 2019 Jun; 2():. PubMed ID: 31528855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
